Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses

Area of Science:

• Immunology
• Transfusion Medicine
• Hematology

Background:

• Red blood cell (RBC) alloimmunization is a major concern for transfusion-dependent patients.
• Antibody formation is typically T cell-dependent, involving non-ABO(H) blood group antigens.
• KEL antigens are a leading cause of hemolytic transfusion reactions.

Purpose of the Study:

• To investigate the role of CD4+ T cells in anti-KEL antibody formation.
• To explore the influence of complement component 3 (C3) on RBC alloimmunization pathways.

Main Methods:

• Investigated KEL RBC alloimmunization in vivo.
• Assessed antibody formation in the presence and absence of CD4+ T cells and C3.
• Manipulated C3 and complement receptor 1/2 (CR1/2) levels in recipient mice.

Main Results:

• KEL RBCs induced antibody formation independently of CD4+ T cells and C3.
• Absence of C3 or CR1/2 made antibody formation CD4+ T cell-dependent.
• C3 appears to regulate the immune pathway involved in RBC alloimmunization.

Conclusions:

• Complement component 3 (C3) plays a critical role in regulating RBC alloimmunization pathways.
• C3 acts as a molecular switch, determining T cell dependence for antibody production.
• Findings offer new insights into managing transfusion reactions and alloimmunization.